← Back to headlines
Genmab Confirms $3.96B DARZALEX Sales in Q1, Driven by U.S. Demand
Genmab announced that its drug DARZALEX generated $3.96 billion in sales during the first quarter, with strong demand from the U.S. market.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
